Yondelis News
Most Popular Yondelis Story
FDA rejects Yondelis-Doxil combo for ovarian cancer
The FDA has rejected Centecor Ortho Biotech's application to market Doxil in combination with Zeltia's Yondelis (trabectedin) as a treatment for ovarian cancer. Following a panel recommendation Read more...
Latest Headlines
- September 25, 2009
- September 10, 2009
- July 16, 2009
- July 13, 2009
- August 7, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
